A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19
Influenza virus and coronavirus, two kinds of pathogens that exist widely in nature, are common emerging pathogens that cause respiratory tract infections in humans. In December 2019, a novel coronavirus SARS-CoV-2 emerged, causing a severe respiratory infection named COVID-19 in humans, and raising...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Series: | International Journal of Molecular Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1422-0067/24/7/6369 |
| _version_ | 1797607793999478784 |
|---|---|
| author | Junhao Luo Zhuohan Zhang Song Zhao Rongbao Gao |
| author_facet | Junhao Luo Zhuohan Zhang Song Zhao Rongbao Gao |
| author_sort | Junhao Luo |
| collection | DOAJ |
| description | Influenza virus and coronavirus, two kinds of pathogens that exist widely in nature, are common emerging pathogens that cause respiratory tract infections in humans. In December 2019, a novel coronavirus SARS-CoV-2 emerged, causing a severe respiratory infection named COVID-19 in humans, and raising a global pandemic which has persisted in the world for almost three years. Influenza virus, a seasonally circulating respiratory pathogen, has caused four global pandemics in humans since 1918 by the emergence of novel variants. Studies have shown that there are certain similarities in transmission mode and pathogenesis between influenza and COVID-19, and vaccination and antiviral drugs are considered to have positive roles as well as several limitations in the prevention and control of both diseases. Comparative understandings would be helpful to the prevention and control of these diseases. Here, we review the study progress in the etiology, pathogenesis, vaccine and antiviral drug development for the two diseases. |
| first_indexed | 2024-03-11T05:35:39Z |
| format | Article |
| id | doaj.art-38ba1c0fb4f9414888661b98cd5f8938 |
| institution | Directory Open Access Journal |
| issn | 1661-6596 1422-0067 |
| language | English |
| last_indexed | 2024-03-11T05:35:39Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | International Journal of Molecular Sciences |
| spelling | doaj.art-38ba1c0fb4f9414888661b98cd5f89382023-11-17T16:50:06ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-03-01247636910.3390/ijms24076369A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19Junhao Luo0Zhuohan Zhang1Song Zhao2Rongbao Gao3NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, ChinaNHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, ChinaNHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, ChinaNHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, ChinaInfluenza virus and coronavirus, two kinds of pathogens that exist widely in nature, are common emerging pathogens that cause respiratory tract infections in humans. In December 2019, a novel coronavirus SARS-CoV-2 emerged, causing a severe respiratory infection named COVID-19 in humans, and raising a global pandemic which has persisted in the world for almost three years. Influenza virus, a seasonally circulating respiratory pathogen, has caused four global pandemics in humans since 1918 by the emergence of novel variants. Studies have shown that there are certain similarities in transmission mode and pathogenesis between influenza and COVID-19, and vaccination and antiviral drugs are considered to have positive roles as well as several limitations in the prevention and control of both diseases. Comparative understandings would be helpful to the prevention and control of these diseases. Here, we review the study progress in the etiology, pathogenesis, vaccine and antiviral drug development for the two diseases.https://www.mdpi.com/1422-0067/24/7/6369SARS-CoV-2influenza virusetiologyspreadpathogenesisvaccines |
| spellingShingle | Junhao Luo Zhuohan Zhang Song Zhao Rongbao Gao A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19 International Journal of Molecular Sciences SARS-CoV-2 influenza virus etiology spread pathogenesis vaccines |
| title | A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19 |
| title_full | A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19 |
| title_fullStr | A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19 |
| title_full_unstemmed | A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19 |
| title_short | A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19 |
| title_sort | comparison of etiology pathogenesis vaccinal and antiviral drug development between influenza and covid 19 |
| topic | SARS-CoV-2 influenza virus etiology spread pathogenesis vaccines |
| url | https://www.mdpi.com/1422-0067/24/7/6369 |
| work_keys_str_mv | AT junhaoluo acomparisonofetiologypathogenesisvaccinalandantiviraldrugdevelopmentbetweeninfluenzaandcovid19 AT zhuohanzhang acomparisonofetiologypathogenesisvaccinalandantiviraldrugdevelopmentbetweeninfluenzaandcovid19 AT songzhao acomparisonofetiologypathogenesisvaccinalandantiviraldrugdevelopmentbetweeninfluenzaandcovid19 AT rongbaogao acomparisonofetiologypathogenesisvaccinalandantiviraldrugdevelopmentbetweeninfluenzaandcovid19 AT junhaoluo comparisonofetiologypathogenesisvaccinalandantiviraldrugdevelopmentbetweeninfluenzaandcovid19 AT zhuohanzhang comparisonofetiologypathogenesisvaccinalandantiviraldrugdevelopmentbetweeninfluenzaandcovid19 AT songzhao comparisonofetiologypathogenesisvaccinalandantiviraldrugdevelopmentbetweeninfluenzaandcovid19 AT rongbaogao comparisonofetiologypathogenesisvaccinalandantiviraldrugdevelopmentbetweeninfluenzaandcovid19 |